Is H9N2 Avian Influenza Virus a Pandemic Potential? by Paul E Alexander, Prithwish De, Supriya Rave

Get full text

The multisystem impact and life-threatening complications of influenza virus: A case series by Anshika Garg, Mukesh Kumar Jain, Sibabratta Patnaik, Bandya Sahoo, Reshmi Mishra

Get full text

Susceptibility of Pandemic Influenza Virus A 2009 H1N1 and Highly Pathogenic Avian Influenza Virus A H5N1 to Antiinfluenza Agents in Cell Culture by I. T. Fedyakina, M. YU. Shchelkanov, P. G. Deryabin, I. A. Leneva, N. V. Gudova, T. V. Kondratyeva, D. K. Lvov

Subjects: “…influenza virus a…”
Get full text

Triazaverin Prophylactic Efficacy Against Influenza Virus A (H5N1) by S. YA. Loginova, S. V. Borisevich, B. A. Maksimov, V. P. Bondarev, S. K. Kotovskaya, V. L. Rusinov, V. N. Charushin, O. N. Chupakhin

Subjects: “…influenza virus a…”
Get full text

Estimation of in vitro Monclavit-1 Virucide Activity against Influenza Virus A (H5N1) by S. YA. Loginova, S. V. Borisevich, G. V. Borisevich, V. P. Bondarev, A. V. Varyukhin

Subjects: “…influenza virus a…”
Get full text

Investigation of in vitro Activity of Ingavirin® Against Influenza Virus A (H3N2) by S. YA. Loginova, S. V. Borisevich, I. V. Semenova, V. A. Maksimov, V. P. Bondarev, V. E. Nebolsin

Subjects: “…influenza virus a…”
Get full text

Characteristics of common pathogens among acute respiratory infection cases in a hospital of Huzhou City by WANG Yan, LUO Peng

Subjects: Get full text

In vitro Efficacy of Ingavirin® against the Pandemic Influenza Virus A(H1N1/09)v by L. N. Shishkina, V. E. Nebolsin, A. S. Kabanov, M. O. Skarnovich, U. B. Erdyneeva, N. A. Mazurkova, O. A. Serova, E. A. Stavsky, I. G. Drozdov

Subjects: “…influenza virus a(h1n1/09)v…”
Get full text

Antigenic variability of influenza viruses A and B isolated from children in Saint-Petersburg in the period 2013–2015 by A. P. Petrova, N. A. Konovalova, D. M. Danilenko, T. G. Lobova, M. Yu. Eropkin, A. I. Zheltukhina, A. D. Vasilieva, E. G. Kornilova, V. S. Afanas’eva

“…Purpose of the study: study of the circulation, isolation and antigenic analysis of influenza viruses A and B in St.-Petersburg in the children aged 0–18 in the seasons 2013–2015.Materials: nasal swabs from children-inpatients from Saint-Petersburg.Methods: virus isolation in MDCK cell culture and chicken embryos, antigenic analysis with the hemagglutination inhibition (HAI) test with the set of hyper-immune rat antisera to the epidemic and reference strains, antigenic cartography.Results: The epidemic seasons 2013–2015 were characterized by the co-circulation in children in St.…”
Get full text

Therapeutic Efficacy of Triazavirin, a Novel Russian Chemotherapeutic, Against Influenza Virus A (H5N1) by S. A. Loginova, S. V. Borisevich, V. A. Maksimov, V. P. Bondarev, S. K. Kotovskaya, V. L. Rusinov, V. N. Charushkin, O. N. Chupakhin

Subjects: “…influenza virus a (h5n1)…”
Get full text

A comprehensive review of the zoonotic potential of avian influenza viruses: a globally circulating threat to pandemic influenza in human by Seyedeh Alemeh Hosseinian, Mohammad Hossein Hajati

Get full text

Protective Activity of Ingavirin® in Experimental Lethal Influenza Due to Pandemic Influenza Virus A (H1N1)v (Albino Mice) by V. V. Zarubaev, A. V. Garshinina, N. A. Kalinina, A. A. Shtro, S. V. Belyaevskaya, V. E. Nebolsin, O. I. Kiselev

Subjects: “…influenza virus a (h1n1)…”
Get full text

Investigation of Ingavirin® Antiviral Activity Against Season Influenza Virus A/H1N1 in MDCK Cell Culture by G. A. Galegov, V. L. Andronova, V. E. Nebolsin

Subjects: “…influenza virus a/h1n1…”
Get full text

Study of Ingavirin® Antiviral Activity against Mexican Pandemic Influenza Virus A/H1N1/2009 in vitro and in vivo by S. YA. Loginova, S. V. Borisevich, V. N. Shchukina, M. V. Lykov, G. V. Borisevich, V. P. Bondarev, V. E. Nebolsin, O. A. Sutochnikova, A. G. Chychalin

Subjects: “…influenza virus a (h1n1)…”
Get full text

Production of the recombinant hemagglutinin protein of the swine influenza virus A/H1N1 and analysis of its physicochemical and antigenic properties by E. D. Avdonina, K. A. Pervoykina, L. V. Verkhovskaya, D. N. Shcherbinin, N. Yu. Viskova, I. S. Kruzhkova, M. A. Ilina, L. V. Kudriavtseva, L. V. Kolobukhina, M. M. Shmarov, N. A. Antipyat, A. L. Gintsburg, I. N. Tyurin

Get full text

Experimental Study of Grippferon Antiviral Activity Against Mexican Pandemic Influenza Virus A/H1N1/2009 in vitro by S. YA. Loginova, S. V. Borisevich, V. N. Shchukina, G. V. Borisevich, V. P. Bondarev, V. A. Shevtsov

Subjects: “…influenza virus a (h1n1)/2009…”
Get full text

Molecular biophysics and inhibition mechanism of influenza virus A M2 viroporin by adamantane-based drugs – Challenges in designing antiviral agents by Kyriakos Georgiou, Dimitrios Kolokouris, Antonios Kolocouris

“…Amantadine received approval for prophylaxis against the influenza virus A in 1966. However, the characterization of the mechanism of action of amantadine targeting AM2 came 50 years after its approval as an anti-influenza A drug. …”
Get full text

Prevalence of Influenza Viruses A and B, Adenovirus, Respiratory Syncytial Virus, and Human Metapneumonia Viruses among Children with Acute Respiratory Tract Infection by Rana Farzi, Neda Pirbonyeh, Mohammad Rahim Kadivar, Afagh Moattari

“…So, this study aimed to evaluate the prevalence of influenza viruses A and B, adenovirus, respiratory syncytial virus (RSV), and human metapneumovirus (HMPV) in children with ARTI. …”
Get full text

Cats as sentinels of mammal exposure to H5Nx avian influenza viruses: a seroprevalence study, France, December 2023 to January 2025 by Jean-Luc Guérin

Get full text

PATHOGENESIS OF MOUSE BRAIN FRONTAL CORTEX DAMAGE iN THE BACKGROUND OF SEASONAL INFLUENZA VIRUS A/H1N1 INFECTION by A. V. Kovner, O. G. Kurskaya, A. M. Shestopalov

Subjects: “…influenza virus a/h1n1…”
Get full text